Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

Authors: Antoine Lurkin, Francoise Ducimetière, Dominique Ranchère Vince, Anne-Valérie Decouvelaere, Dominic Cellier, François N Gilly, Dimitri Salameire, Pierre Biron, Guy de Laroche, Jean Yves Blay, Isabelle Ray-Coquard

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Sarcomas are rare malignant tumors. Accurate initial histological diagnosis is essential for adequate management. We prospectively assessed the medical management of all patients diagnosed with sarcoma in a European region over a one-year period to identify the quantity of first diagnosis compared to central expert review (CER).

Methods

Histological data of all patients diagnosed with sarcoma in Rhone-Alpes between March 2005 and Feb 2006 were collected. Primary diagnoses were systematically compared with second opinion from regional and national experts.

Results

Of 448 patients included, 366 (82%) matched the inclusion criteria and were analyzed. Of these, 199 (54%) had full concordance between primary diagnosis and second opinion (the first pathologist and the expert reached identical conclusions), 97 (27%) had partial concordance (identical diagnosis of conjonctive tumor but different grade or subtype), and 70 (19%) had complete discordance (different histological type or invalidation of the diagnosis of sarcoma). The major discrepancies were related to histological grade (n = 68, 19%), histological type (n = 39, 11%), subtype (n = 17, 5%), and grade plus subtype or grade plus histological type (n = 43, 12%).

Conclusions

Over 45% of first histological diagnoses were modified at second reading, possibly resulting in different treatment decisions. Systematic second expert opinion improves the quality of diagnosis and possibly the management of patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, et al: Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev. 1997, 6 (5): 442-66. 10.1097/00008469-199710000-00005.CrossRefPubMed Menegoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buemi A, et al: Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev. 1997, 6 (5): 442-66. 10.1097/00008469-199710000-00005.CrossRefPubMed
2.
go back to reference Clark MA, Fisher C, Judson I, Thomas JM: Soft-tissue sarcomas in adults. N Engl J Med. 2005, 353 (7): 701-11. 10.1056/NEJMra041866.CrossRefPubMed Clark MA, Fisher C, Judson I, Thomas JM: Soft-tissue sarcomas in adults. N Engl J Med. 2005, 353 (7): 701-11. 10.1056/NEJMra041866.CrossRefPubMed
3.
go back to reference Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin JY, Sunyach MP, et al: Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004, 15 (2): 307-15. 10.1093/annonc/mdh058.CrossRefPubMed Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin JY, Sunyach MP, et al: Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004, 15 (2): 307-15. 10.1093/annonc/mdh058.CrossRefPubMed
4.
go back to reference Fletcher CD, Unni KK, Mertens F: WHO classification of tumors. Pathology and genetics. Tumors of Soft Tissue and Bone. 2002, IARC press Fletcher CD, Unni KK, Mertens F: WHO classification of tumors. Pathology and genetics. Tumors of Soft Tissue and Bone. 2002, IARC press
5.
go back to reference Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY: Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008, 19 (Suppl 2): ii89-ii93. 10.1093/annonc/mdn101.PubMed Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY: Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008, 19 (Suppl 2): ii89-ii93. 10.1093/annonc/mdn101.PubMed
6.
go back to reference Arbiser ZK, Folpe AL, Weiss SW: Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001, 116 (4): 473-6. 10.1309/425H-NW4W-XC9A-005H.CrossRefPubMed Arbiser ZK, Folpe AL, Weiss SW: Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001, 116 (4): 473-6. 10.1309/425H-NW4W-XC9A-005H.CrossRefPubMed
7.
go back to reference Coindre JM, Nguyen BB, Goussot JF, De MI, Maree D, De Mascarel A, et al: [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol. 1985, 5 (2): 95-9.PubMed Coindre JM, Nguyen BB, Goussot JF, De MI, Maree D, De Mascarel A, et al: [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol. 1985, 5 (2): 95-9.PubMed
8.
go back to reference Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986, 58 (2): 306-9. 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO;2-7.CrossRefPubMed Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, et al: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986, 58 (2): 306-9. 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO;2-7.CrossRefPubMed
9.
go back to reference Harris M, Hartley AL, Blair V, Birch JM, Banerjee SS, Freemont AJ, et al: Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991, 64 (2): 315-20.CrossRefPubMedPubMedCentral Harris M, Hartley AL, Blair V, Birch JM, Banerjee SS, Freemont AJ, et al: Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991, 64 (2): 315-20.CrossRefPubMedPubMedCentral
10.
go back to reference Katenkamp D: Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas. Pathol Res Pract. 1988, 183 (6): 698-705.CrossRefPubMed Katenkamp D: Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas. Pathol Res Pract. 1988, 183 (6): 698-705.CrossRefPubMed
11.
go back to reference Tomaszewski JE, Bear HD, Connally JA, Epstein JI, Feldman M, Foucar K, et al: Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol. 2000, 114 (3): 329-35.PubMed Tomaszewski JE, Bear HD, Connally JA, Epstein JI, Feldman M, Foucar K, et al: Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol. 2000, 114 (3): 329-35.PubMed
12.
go back to reference Lind AC, Bewtra C, Healy JC, Sims KL: Prospective peer review in surgical pathology. Am J Clin Pathol. 1995, 104 (5): 560-6.CrossRefPubMed Lind AC, Bewtra C, Healy JC, Sims KL: Prospective peer review in surgical pathology. Am J Clin Pathol. 1995, 104 (5): 560-6.CrossRefPubMed
13.
go back to reference Kronz JD, Westra WH, Epstein JI: Mandatory second opinion surgical pathology at a large referral hospital. Cancer. 1999, 86 (11): 2426-35. 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3.CrossRefPubMed Kronz JD, Westra WH, Epstein JI: Mandatory second opinion surgical pathology at a large referral hospital. Cancer. 1999, 86 (11): 2426-35. 10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3.CrossRefPubMed
14.
go back to reference Ducimetiere A, Lurkin D, Ranchere-Vince P, Biron M, Peoch L, Istier D, Salameire P, Chalabreysse J, Blay Y, Ray-Coquard I: Exhaustive prospective collection of new sarcomas: Report of an unexpectedly high incidence. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2007, 25 (No 18S (June 20 Supplement)): 20513- Ducimetiere A, Lurkin D, Ranchere-Vince P, Biron M, Peoch L, Istier D, Salameire P, Chalabreysse J, Blay Y, Ray-Coquard I: Exhaustive prospective collection of new sarcomas: Report of an unexpectedly high incidence. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2007, 25 (No 18S (June 20 Supplement)): 20513-
15.
go back to reference Berger C, Trombert-Paviot B, Mitton N, Frappaz D, Galambrun C, Plantaz D, et al: [Childhood cancer incidence and survival rates in the Rhone-Alpes regional paediatric registry 1987-1999]. Arch Pediatr. 2006, 13 (2): 121-9. 10.1016/j.arcped.2005.10.022.CrossRefPubMed Berger C, Trombert-Paviot B, Mitton N, Frappaz D, Galambrun C, Plantaz D, et al: [Childhood cancer incidence and survival rates in the Rhone-Alpes regional paediatric registry 1987-1999]. Arch Pediatr. 2006, 13 (2): 121-9. 10.1016/j.arcped.2005.10.022.CrossRefPubMed
16.
go back to reference Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P: Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer. 2008, 50 (6): 1213-20. 10.1002/pbc.21506.CrossRefPubMed Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P: Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer. 2008, 50 (6): 1213-20. 10.1002/pbc.21506.CrossRefPubMed
17.
go back to reference Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997, 15 (1): 350-62.PubMed Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997, 15 (1): 350-62.PubMed
18.
go back to reference Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960, 20: 27-46. 10.1177/001316446002000104.CrossRef Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960, 20: 27-46. 10.1177/001316446002000104.CrossRef
19.
go back to reference Fleiss JL, Cohen J, Everitt BS: Large sample standard errors of kappa and weighted kappa. Psychol Bull. 1969, 72: 323-327. 10.1037/h0028106.CrossRef Fleiss JL, Cohen J, Everitt BS: Large sample standard errors of kappa and weighted kappa. Psychol Bull. 1969, 72: 323-327. 10.1037/h0028106.CrossRef
20.
go back to reference Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ: Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995, 221 (2): 185-95. 10.1097/00000658-199502000-00009.CrossRefPubMedPubMedCentral Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ: Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995, 221 (2): 185-95. 10.1097/00000658-199502000-00009.CrossRefPubMedPubMedCentral
21.
go back to reference Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM: Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996, 14 (4): 1201-8.PubMed Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM: Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996, 14 (4): 1201-8.PubMed
22.
go back to reference Enzinger FM: Soft tissue tumours. 2001, Weiss SW. St Louis: Mosby, 4 Enzinger FM: Soft tissue tumours. 2001, Weiss SW. St Louis: Mosby, 4
23.
go back to reference Reichardt P: High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol. 2002, 41 (2): 157-67. 10.1016/S1040-8428(01)00153-6.CrossRefPubMed Reichardt P: High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol. 2002, 41 (2): 157-67. 10.1016/S1040-8428(01)00153-6.CrossRefPubMed
24.
go back to reference Coindre JM: [Recommendations for anatamo-pathologic management of soft tissue sarcomas in the adult. Pathologists of the FNCLCC Sarcoma Group (Federation Nationale des Centres de Lutte Contre le Cancer)]. Ann Pathol. 1998, 18 (6): 505-11.PubMed Coindre JM: [Recommendations for anatamo-pathologic management of soft tissue sarcomas in the adult. Pathologists of the FNCLCC Sarcoma Group (Federation Nationale des Centres de Lutte Contre le Cancer)]. Ann Pathol. 1998, 18 (6): 505-11.PubMed
25.
go back to reference Coindre JM: Histologic grading of adult soft tissue sarcomas. Verh Dtsch Ges Pathol. 1998, 82: 59-63.PubMed Coindre JM: Histologic grading of adult soft tissue sarcomas. Verh Dtsch Ges Pathol. 1998, 82: 59-63.PubMed
26.
go back to reference Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K, et al: Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol. 2002, 33 (1): 111-5. 10.1053/hupa.2002.30184.CrossRefPubMed Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K, et al: Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol. 2002, 33 (1): 111-5. 10.1053/hupa.2002.30184.CrossRefPubMed
27.
go back to reference Lehnhardt M, Daigeler A, Hauser J, Puls A, Soimaru C, Kuhnen C, et al: The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol. 2008, 97 (1): 40-3. 10.1002/jso.20897.CrossRefPubMed Lehnhardt M, Daigeler A, Hauser J, Puls A, Soimaru C, Kuhnen C, et al: The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol. 2008, 97 (1): 40-3. 10.1002/jso.20897.CrossRefPubMed
28.
go back to reference Bridge JA, Sandberg AA: Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000, 29 (5): 249-58. 10.1007/s002560050603.CrossRefPubMed Bridge JA, Sandberg AA: Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000, 29 (5): 249-58. 10.1007/s002560050603.CrossRefPubMed
29.
go back to reference Coindre JM: Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003, 43 (1): 1-16. 10.1046/j.1365-2559.2003.01639.x.CrossRefPubMed Coindre JM: Immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology. 2003, 43 (1): 1-16. 10.1046/j.1365-2559.2003.01639.x.CrossRefPubMed
30.
go back to reference Ladanyi M, Bridge JA: Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol. 2000, 31 (5): 532-8. 10.1053/hp.2000.6706.CrossRefPubMed Ladanyi M, Bridge JA: Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol. 2000, 31 (5): 532-8. 10.1053/hp.2000.6706.CrossRefPubMed
31.
go back to reference Ordóñez NG: Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol. 1998, 5: 67-85. 10.1097/00125480-199801000-00051.CrossRefPubMed Ordóñez NG: Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol. 1998, 5: 67-85. 10.1097/00125480-199801000-00051.CrossRefPubMed
32.
go back to reference Yamaguchi U, Hasegawa T: [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment]. Gan To Kagaku Ryoho. 2004, 31 (9): 1340-5.PubMed Yamaguchi U, Hasegawa T: [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment]. Gan To Kagaku Ryoho. 2004, 31 (9): 1340-5.PubMed
33.
go back to reference Meis-Kindblom JM, Bjerkehage B, Bohling T, Domanski H, Halvorsen TB, Larsson O, et al: Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl. 1999, 285: 18-26.PubMed Meis-Kindblom JM, Bjerkehage B, Bohling T, Domanski H, Halvorsen TB, Larsson O, et al: Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl. 1999, 285: 18-26.PubMed
34.
go back to reference Presant CA, Russell WO, Alexander RW, Fu YS: Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986, 4 (11): 1658-61.PubMed Presant CA, Russell WO, Alexander RW, Fu YS: Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol. 1986, 4 (11): 1658-61.PubMed
35.
go back to reference Randall RL, Bruckner JD, Papenhausen MD, Thurman T, Conrad EU: Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers. Orthopedics. 2004, 27 (2): 209-12.PubMed Randall RL, Bruckner JD, Papenhausen MD, Thurman T, Conrad EU: Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers. Orthopedics. 2004, 27 (2): 209-12.PubMed
36.
go back to reference Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, et al: Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer. 1989, 64 (2): 484-90. 10.1002/1097-0142(19890715)64:2<484::AID-CNCR2820640223>3.0.CO;2-T.CrossRefPubMed Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, et al: Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer. 1989, 64 (2): 484-90. 10.1002/1097-0142(19890715)64:2<484::AID-CNCR2820640223>3.0.CO;2-T.CrossRefPubMed
37.
go back to reference Westra WH, Kronz JD, Eisele DW: The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital. Head Neck. 2002, 24 (7): 684-93. 10.1002/hed.10105.CrossRefPubMed Westra WH, Kronz JD, Eisele DW: The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital. Head Neck. 2002, 24 (7): 684-93. 10.1002/hed.10105.CrossRefPubMed
38.
go back to reference Matasar MJ, Shi W, Silberstien J, et al: Expert second opinion pathology review of lymphoma in the Era of the world health organization classification. Blood. 2007 Matasar MJ, Shi W, Silberstien J, et al: Expert second opinion pathology review of lymphoma in the Era of the world health organization classification. Blood. 2007
39.
go back to reference Piver MS, Tsukada Y, Werness BA, Dicioccio RA, Whittemore AS, Ponder BA: Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecol Oncol. 2000, 78 (2): 166-70. 10.1006/gyno.2000.5840.CrossRefPubMed Piver MS, Tsukada Y, Werness BA, Dicioccio RA, Whittemore AS, Ponder BA: Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecol Oncol. 2000, 78 (2): 166-70. 10.1006/gyno.2000.5840.CrossRefPubMed
Metadata
Title
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
Authors
Antoine Lurkin
Francoise Ducimetière
Dominique Ranchère Vince
Anne-Valérie Decouvelaere
Dominic Cellier
François N Gilly
Dimitri Salameire
Pierre Biron
Guy de Laroche
Jean Yves Blay
Isabelle Ray-Coquard
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-150

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine